Achilles Tendinopathy: What Works, What Doesn't, and Where PEMF Fits

Updated August 2026 · 18 min read · Main Clinical Reference

Clinical foot and ankle examination for Achilles tendinopathy in a runner

Written by: PainFree Medical Content Team

Published: June 2026 | Last updated: 17 August 2026

Every clinical claim on this page links to its own PubMed or PMC source — including the two randomised trials that did not find an advantage for PEMF over eccentric exercise alone. An article about Achilles tendinopathy that reports only the favourable findings is a sales page, not a clinical one.

Achilles tendinopathy is one of the most common overuse injuries in runners and endurance athletes — up to roughly 50% of runners experience Achilles symptoms at some point. The Achilles tendon is the strongest tendon in the body, yet it absorbs loads of up to 12× body weight with every running stride. When cumulative load outpaces the tendon's capacity to repair, the result is pain, morning stiffness, and reduced performance.

This is PainFree Philippines' main reference page on Achilles tendinopathy. It covers the symptoms, the differential diagnosis, what the research genuinely shows about PEMF (Pulsed Electromagnetic Field) therapy, the clinical protocol, and the difference between mid-portion and insertional disease — which determines what loading a patient is allowed to do.

In this guide:

What Achilles tendinopathy actually is
Mid-portion vs insertional — two different conditions
Differential diagnosis table
How PEMF acts on tendon tissue
What the evidence says — including what it does not support
What the clinical guidelines recommend
Clinical protocol
Treatment options compared
Clinical system, home device or consumer product?
Integrative care — combining modalities
Frequently asked questions
For clinics and investors

What Achilles tendinopathy actually is

Despite the common name "Achilles tendinitis", most chronic cases are not classic acute inflammation. They are degenerative changes in the tendon matrix — disorganised collagen, increased ground substance and neovascularisation — caused by repetitive load that outpaces repair. This distinction matters clinically: it is why anti-inflammatory strategies alone rarely resolve the problem, and why graded mechanical loading does.

The typical presentation is pain and stiffness in the first steps out of bed in the morning, easing after a few minutes of walking, then returning and intensifying hours after activity. Pain sits behind the heel, along the tendon itself — not underneath the heel, which points to plantar fasciitis instead.

Mid-portion or insertional — two conditions with one name

Direct answer: these are two separate conditions that share a label. Mid-portion tendinopathy sits 2–6 cm above the heel and responds well to classic eccentric heel-drop loading below step level. Insertional tendinopathy sits at the attachment to the calcaneus, and classic eccentric loading can make it worse, because deep dorsiflexion compresses the tendon against the bone. Loading there is performed in a restricted range, without dropping below floor level.

This distinction determines the loading programme, the footwear advice and the expected rate of improvement — so it is the first thing to confirm in the medical summary. Full detail on the insertional form: insertional Achilles tendinopathy and the heel attachment.

Differential diagnosis — what else it could be

Condition	Pain location	Distinguishing feature	Is PEMF relevant?
Mid-portion Achilles tendinopathy	2–6 cm above the heel, behind the leg	Morning stiffness in the first steps, eases with warm-up	Yes — as an adjunct for pain, alongside eccentric loading
Insertional Achilles tendinopathy	At the calcaneal attachment	Worse in deep dorsiflexion and in stiff-backed shoes	Yes — with a modified loading range
Plantar fasciitis / heel spur	Underneath the heel	Sharpest pain on the first step out of bed	Separate condition — see the dedicated article
Partial or complete tendon rupture	Along the tendon, usually sudden	A "kick" sensation, palpable gap, positive Thompson test	No — urgent orthopaedic referral
Calcaneal stress fracture	In the body of the heel bone	Pain on medial-lateral squeeze, follows a sharp load increase	Separate condition — imaging first

How PEMF acts on tendon tissue

PEMF is a low-intensity, non-thermal, non-invasive pulsed electromagnetic field therapy. The coil is placed over the tendon, the patient feels nothing, and the system runs on its own for the session. The mechanisms described in the literature are:

Improved microcirculation — increased nitric oxide availability and local vasodilation, which matters in a structure as poorly vascularised as the Achilles tendon.
Reduced oedema and inflammatory mediators in soft tissue.
Support for cellular activity — ATP production and tenocyte function, the cells that build and maintain collagen fibres.
Pain reduction — the most consistently reported effect, and the clinical reason the modality is combined into a programme.

Tissue-level support comes from Strauch et al. (Aesthetic Surgery Journal, 2009, Albert Einstein College of Medicine, PubMed 19371845), describing pain and oedema relief, soft-tissue healing and angiogenesis. This is a mechanistic explanation at tissue level — not condition-specific clinical proof for the Achilles tendon.

What the evidence says — including what it does not support

Direct answer: the Achilles-specific randomised evidence does not show that PEMF improves outcomes beyond eccentric exercise. The supporting evidence is stronger for pain reduction across foot and ankle soft-tissue conditions generally.

The dedicated randomised trial (2024). A randomised controlled trial published in the Orthopaedic Journal of Sports Medicine (2024, PubMed 39534390) enrolled 65 participants with Achilles tendinopathy: 33 received active PEMF and 32 received sham, and both groups performed 12 weeks of eccentric exercise. The primary outcome (VISA-A) improved significantly in both groups — from 57.9 to 71.7 with PEMF and from 55.1 to 66.8 with sham — but with no significant difference between groups (p=0.527). Pain scores showed no between-group difference either (p=0.346), and there was no effect on tendon neovascularity. The investigators concluded that PEMF added to eccentric exercise did not improve outcomes over exercise alone.

Long-term follow-up (2026). A follow-up published in Scientific Reports (2026, PubMed 41651914) reported the same cohort (n=65, NCT05316961) out to 26 weeks. Both groups showed substantial improvement across all outcomes, sustained at follow-up. This is the same trial, not an independent one. The authors describe PEMF as a promising non-invasive approach and explicitly call for further work on optimal dosing.

Systematic review across the foot and ankle (2026). A systematic review in Frontiers in Sports and Active Living (2026, PubMed 41716305) included 4 randomised trials (n=243, mean age 48.8) in foot and ankle soft-tissue pathologies. Three of the four reported statistically significant pain reduction in the intervention groups (p<0.05), but only 1 of 3 showed significant functional improvement. The reviewers note large heterogeneity in treatment protocols. No serious adverse events were reported; the only documented side effect was minor skin redness.

An earlier feasibility study, and why it is weaker. A prospective study in the Journal of Foot and Ankle Surgery (2018, PubMed 28842106) included 53 patients with chronic mid-portion Achilles tendinopathy: 28 treated with an 80 mT electromagnetic device (8 treatments over 4 weeks) and 25 with heel cushions only. At 12 weeks both groups improved and the active group showed significantly better pain scores. Important caveat: this was a non-randomised, unblinded feasibility study, and the control group received heel cushions rather than eccentric loading — so the comparison is not against the evidence-based treatment.

What happens in the tissue itself — preclinical. A rat model of Achilles tendinopathy (Bone & Joint Research, 2022, PubMed 33072305) exposed 68 animals to PEMF (1.5 mT, 75 Hz) and found improved collagen fibre organisation and healing, with timing relative to disease stage affecting the result. This is an animal study — it explains why the mechanism is plausible and says nothing definitive about clinical outcomes in humans.

The wider background. A 2025 prospective multi-centre randomised trial (PMC11914662, n=91, 5 orthopaedic clinics) reported 36% pain reduction versus 10% with standard care (p<0.0001) and a 55% reduction in medication use. To be clear: that trial studied joint and soft-tissue pain in general — not Achilles tendinopathy specifically. It supports the general tissue-level effect and the medication-sparing effect; it is not condition-specific proof here.

What the clinical guidelines recommend

Direct answer: mainstream guidance places graded conservative care first, with eccentric or heavy slow resistance loading carrying the strongest evidence base.

Most patients improve without surgery. A graded loading programme of at least 12 weeks is the default; 3–6 months is often needed for meaningful improvement.
Complete rest is not recommended. Relative load reduction beats full cessation — the tendon needs controlled mechanical stimulus to adapt.
Steroid injection into the tendon body is considered problematic because of the risk of weakening the tendon.
Antibiotics do not treat tendinopathy — it is not an infection. Fluoroquinolone antibiotics are in fact associated with an increased risk of tendon injury and rupture, and recent use should be reported to the treating physician.
Surgery is reserved for resistant cases that have not responded to at least six months of structured conservative care, or for structural rupture.
Where PEMF fits: an adjunct within an overall programme, primarily for pain reduction and to support adherence to loading — not a replacement for medical assessment or rehabilitation.

Clinical protocol

Assessment and differential diagnosis — history (symptom duration, load changes, medication including fluoroquinolones), palpation to localise pain (mid-portion vs insertional), Thompson test to exclude rupture, dorsiflexion range and calf strength.
Define the treatment target — PEMF is added when pain limits the patient's ability to perform the loading programme. If the patient can already load without limitation, the expected benefit is lower.
Coil placement — over the painful region along the tendon, patient prone with the ankle free. The system selects frequency, waveform and duty cycle according to the chosen indication.
Session duration — approximately 30 minutes. The treatment is painless and does not require continuous practitioner supervision in the room.
Frequency — 1–2 times per week (up to 3 in an acute phase, with a rest day between sessions).
Series length — typically 8–12 sessions, alongside a daily loading programme of at least 12 weeks.
Active exercise immediately after the session, in the same visit — the analgesic window is the point of the modality.

Treatment options compared

Parameter	Eccentric loading	PEMF	Shockwave (ESWT)	Corticosteroid injection
Evidence base in Achilles tendinopathy	Strongest — first-line	Mixed; no advantage over loading in the dedicated RCT	Moderate, mainly in resistant cases	Weak; risk of tendon weakening
Invasiveness	None	None	Non-invasive, can be painful	Injection
Pain during treatment	Often some discomfort	None	Frequently uncomfortable	Procedural
Practitioner time per session	Supervision and coaching	Hands-free — no continuous supervision required	Continuous operation	Physician procedure
Main role	Rebuilds tendon capacity	Reduces pain, supports adherence to loading	Stimulates remodelling	Short-term symptom control

Clinical system, medical-grade home device, or consumer product?

Three separate categories exist in the market, and a clinic must be able to explain the difference to a patient who arrives after a Google search:

Clinical PEMF system — operated in a clinic after diagnosis; high field intensity, full coil range, indication-specific protocol library.
Medical-grade home device — rented or sold to patients for home rehabilitation; preset programmes, simple operation, usable while reading or watching television.
Consumer wellness product (mats and mattresses) — a consumer good, not medical equipment, with no defined indication.

On intensity versus frequency: the medical-grade home device is stronger than common consumer home units and less powerful than the clinical system. Its advantage is not intensity but frequency: a clinic treats once or twice a week, whereas at home treatment can be daily, even twice daily. In Achilles tendinopathy that matters, because the eccentric programme is itself a daily 12-week commitment and the analgesic window is what makes it achievable. A home device does not replace diagnosis and is never a reason to delay assessment — particularly where rupture is suspected.

Integrative care — combining modalities

Integrative care is the combination of advanced medical technology, targeted treatment and rehabilitative or complementary medicine. What is known from research: a Cochrane review published in the BMJ (PubMed 25694111, Kamper 2015) examined multidisciplinary biopsychosocial rehabilitation versus usual care across 41 randomised trials and 6,858 patients, and found a positive but moderate effect — pain SMD 0.21 (95% CI 0.04–0.37), disability SMD 0.23 (0.06–0.40), moderate-quality evidence. The caveat matters: a combination being mechanistically sensible is not proof that it outperforms each component alone — each pairing has to be tested. As the evidence section above shows, in Achilles tendinopathy the specific pairing of PEMF with eccentric exercise was tested and did not beat exercise alone.

Frequently Asked Questions

⚠️ When is urgent medical assessment required?

Immediately, with any of these four signs: sudden sharp pain with a "kick" sensation in the calf, inability to stand on tiptoe, a palpable gap in the tendon, or marked weakness in plantarflexion. Each raises suspicion of Achilles rupture and requires urgent orthopaedic assessment — not a course of treatment. Redness, local heat, fever or persistent night pain unrelated to load also require investigation before any treatment begins.

What exact diagnosis is written in your medical summary?

"Achilles tendinitis" is an umbrella term. Check whether the summary says mid-portion Achilles tendinopathy, insertional Achilles tendinopathy, retrocalcaneal bursitis, paratendinitis, or partial tear. The distinction is not academic: the protocol, the loading programme, the series length and the expected outcome all follow from it — classic eccentric loading suits mid-portion disease and can aggravate the insertional form.

Is PEMF effective for Achilles tendinopathy? What do the numbers say?

Two reports of one randomised trial (n=65) found no advantage over eccentric exercise alone. A 2026 systematic review of 4 trials (n=243) in foot and ankle soft-tissue conditions found significant pain reduction in 3 of 4 studies, and functional improvement in only 1 of 3. The honest summary: reasonable as an adjunct for pain, not a substitute for loading.

Is PEMF treatment painful?

No. PEMF is painless — patients typically feel nothing or only mild warmth. There are no needles and no medication, and no need to undress, which makes it easy to combine with an active rehabilitation programme.

How long until I see improvement?

Some patients notice relief after a few sessions. Meaningful tendon remodelling takes longer: measurable improvement usually develops over several weeks of consistent treatment combined with eccentric loading. Tendons remodel slowly by nature, and 3–6 months is a realistic horizon.

Can I keep training during treatment?

Often yes, with modified load. In the acute phase, training volume should be reduced relative to your normal programme. Controlled return to running is reintroduced as symptoms settle. The goal is to stay active without re-overloading the tendon — complete rest is not recommended.

Does PEMF replace eccentric loading exercises?

No, and this is the central point. Eccentric loading is the evidence-based foundation of Achilles rehabilitation. PEMF is an adjunct that reduces pain and supports the tissue environment; it is not a substitute for the loading programme.

If the trial was negative, why combine PEMF at all?

Because the published protocol of that same trial (Trials 2023, PubMed 37308969) states the clinical problem plainly: most patients have moderate to severe pain that reduces the incentive to perform eccentric exercise, and few sustain it for three consecutive months — which is exactly the duration required. The defensible role of PEMF is opening a pain-reduction window that makes the loading programme achievable. It is measured by the adherence it produces, not by what it does in isolation.

Can PEMF be combined with shockwave therapy?

Yes, and it is common practice — PEMF supporting circulation and reducing pain, shockwave stimulating remodelling, and loading rebuilding tendon capacity. Combination rather than isolation is the pattern that clinics report.

What is the operational benefit of PEMF for a clinic?

Unlike shockwave or hands-on physiotherapy, PEMF does not require continuous practitioner supervision during the session. A staff member sets the patient up and the system runs, which improves clinic throughput and economics. Typical session pricing in the market is around ₱1,500–₱2,500 per session. Note that this is not "zero practitioner time" — positioning the coils and setting the protocol takes time.

For clinics and investors

A PEMF system increases clinic revenue for several reasons:

Better treatment outcomes through integrative care. The documented effect of a multidisciplinary approach is positive but moderate (Kamper 2015, PubMed 25694111: 41 RCTs, n=6,858) — not "proven".
The range of treatable indications widens substantially — including patients with contraindications to manual therapy.
Lower patient-acquisition cost relative to competing treatments.
Hands-free delivery. The session does not require continuous supervision, so the revenue is additional to the manual-therapy fee rather than competing with it.
A professional support envelope — clinical training, a structured protocol book, and ongoing technical and clinical support.
Meaningful differentiation in a crowded market where most competitors offer a single modality.

What to verify with any supplier: regulatory registration for the specific model offered to you and its validity date, IEC 60601 electrical safety, ICNIRP compliance, an indication-specific protocol library, and structured clinical training. ⚠️ Regulatory clearance always belongs to a specific model and has an expiry — a supplier presenting company-level or technology-level clearance instead of model-level clearance is the first thing to examine closely.

Related guides

Sources

Interested in adding PEMF to your clinic?

Request the full investment brief — machine specs, financials, and site selection for the Philippines market.

Request Investment Brief →

PainFree operates 70+ Israeli clinics serving a population of 9M — now expanding to the Philippines.

PEMF for AchillesTendinopathy.